Chronic Lymphocytic Leukemia SpecialistsPage 3

Joseph Jurcic, MD

Professor of Medicine; Director, Hematologic Malignancies Section, Division of Hematology/Oncology

Hematology

Matthew Davids, M.D.

Director of Clinical Research, as well as Associate Director of the CLL Center. He is also an Associate Professor of Medicine at Harvard Medical School, and a; Director, Clinical Research, Division of Lymphoma

Hematology

Jonathan Kolitz, MD

Head, Leukemia Service

Hematology

David Scheinberg, MD

Vincent Astor Chair and Chairman, Molecular Pharmacology Program, Sloan Kettering Institute; Professor of Medicine, Weill Cornell Medicine

Oncology

Nelson Kalil, M.D.

Hematology

Ranjit Nair, M.D

Associate Professor, Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center; Clinical Medical Director, Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center

Hematology

Shaker Dakhil, MD

President, Cancer Center of Kansas

Hematology

Ricardo Parrondo, M.D.

Hematology

Caron Jacobson, MD

Director, Immune Effector Cell Therapy Program; Senior Physician

Hematology

Mazie Tsang, M.D.

Hematology

Ian Flinn, M.D.

Hematology

Christopher Flowers, M.D.

Division Head of Cancer Medicine and Chair, Department of Lymphoma-Myeloma

Hematology

Michael Grossbard, MD

Professor, Department of Medicine

Hematology

Lindsey Roeker, M.D.

Senior Associate Consultant, Hematology

Hematology

Philippe Armand, MD, PHD

Chief, Division of Lymphoma

Hematology

Aaron Logan, MD, PHD

Professor of Clinical Medicine

Hematology

Jacob Soumerai, MD

Clinical Investigator in Lymphoma

Hematology

Karen Chee, M.D.

Hematology Oncology

Hematology

Ivana Micallef, M.D.

Section Head, Division of Hematology

Hematology

Alexander Hindenburg, M.D.

Assistant Professor, Department of Medicine

Hematology